June 18, 2021 10:57 AM EDTUpdated 11:11 AM

Jim Greenwood opens new policy shop, with an eye on drug price controls; Moderna, CRISPR, Mustang receive tax breaks in Massachusetts

Josh Sullivan

Zachary Brennan

Senior Editor

Capitol Hill heavyweight Jim Greenwood is taking his decades of experience in the intertwining worlds of biopharma and Congress to the law firm DLA Piper …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Jim Greenwood opens new policy shop, with an eye on drug price controls; Moderna, CRISPR, Mustang receive tax breaks in Massachusetts

Josh Sullivan

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Patient dies in Neurogene's Rett syndrome study

Are programs with compounded GLP-1s safe for your population?

Jim Green­wood opens new pol­i­cy shop, with an eye on drug price con­trols; Mod­er­na, CRISPR, Mus­tang re­ceive tax breaks in Mass­a­chu­setts

Senior Editor

Sign up to read this article for free.

Jim Greenwood opens new policy shop, with an eye on drug price controls; Moderna, CRISPR, Mustang receive tax breaks in Massachusetts